Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action
- 17 June 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 355 (9221), 2125-2131
- https://doi.org/10.1016/s0140-6736(00)02380-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Phase I and Pharmacologic Study of Oral Fluorouracil on a Chronic Daily Schedule in Combination With the Dihydropyrimidine Dehydrogenase Inactivator EniluracilJournal of Clinical Oncology, 2000
- Eniluracil Treatment Completely Inactivates Dihydropyrimidine Dehydrogenase in Colorectal TumorsJournal of Clinical Oncology, 1999
- Tumor, Normal Tissue, and Plasma Pharmacokinetic Studies of Fluorouracil Biomodulation With N-Phosphonacetyl-l-aspartate, Folinic Acid, and Interferon AlfaJournal of Clinical Oncology, 1999
- Intra- and extracellular fluorouracil uptake: assessment with contrast-enhanced metabolic F-19 MR imaging.Radiology, 1998
- Uptake of neutral α- and β-amino acids by human proximal tubular cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- 5-Ethynyluracil (776C85): Protection from 5-fluorouracil-induced neurotoxicity in dogsBiochemical Pharmacology, 1994
- 5-ethynyluracil (776C85): Inactivation of dihydropyrimidine dehydrogenase in vivoBiochemical Pharmacology, 1993
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.JCI Insight, 1988
- Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapyMagnetic Resonance Imaging, 1987